Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine Approach [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing antipsychotic dose reduction versus maintenance treatment in people with schizophrenia spectrum disorders, aiming to personal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Patient With Schizophrenia Spectrum Disorder, NLM Classification WM 203, Psychology:Schizophrenic Psychology | Phase 2 | Status: NOT_YET_RECRUITING